Patents by Inventor Masahiro Iwamoto
Masahiro Iwamoto has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Publication number: 20240074002Abstract: A heating cooking apparatus includes a housing, a cover portion, a fan, a first heater, a temperature detection unit, and a wall portion. The housing has an opening. The cover portion has a suction hole portion and a blow-out hole portion, and covers the opening. The fan is disposed in the housing and generates an air flow from the suction hole portion to the blow-out hole portion. The first heater is disposed in the housing. The temperature detection unit is disposed in the housing and detects a temperature. The wall portion is disposed on an upstream side of the temperature detection unit in an air flow direction.Type: ApplicationFiled: January 6, 2022Publication date: February 29, 2024Inventors: MASAHIRO NISHIJIMA, MASAYUKI IWAMOTO
-
Patent number: 11833256Abstract: The invention relates to compositions and methods as part of a pharmacotherapeutic strategy that targets the endochondral ossification process in a pharmacologically selective and site-specific manner. A variety of orthopedic pathologies are caused by or associated with generalized or local dysregulation of endochondral ossification, for example trauma to the bone growth plate or diaphysis can cause a serious imbalance in bone growth, leading to progressive deformity that today can only be treated surgically. Dysregulated endochondral ossification is also behind heterotopic ossification, which arises in soft tissues and causes pain, decrease in mobility and other clinical problems. The invention therefore provides RARy agonist and antagonist nanoparticle compositions for treating abnormal endochondral ossification and bone growth that can deliver robust local therapeutic control over a particular long bone's growth with a long-lasting effect.Type: GrantFiled: June 20, 2018Date of Patent: December 5, 2023Assignees: University of Maryland, Baltimore, The Children's Hospital of PhiladelphiaInventors: Masahiro Iwamoto, Michael Chorny
-
Publication number: 20230201146Abstract: The invention provides methods for muscle repair or regeneration comprising administering therapeutically effective amounts of RAR agonists or stem cells that are pretreated with contact with a RAR agonist to a subject at a site of muscle damage. Additionally, the invention provides compositions comprising RAR agonist treated stem cells and methods of use of said cells for muscle repair or regeneration. In one embodiment, the stem cells are mesenchymal stem cells. In one embodiment, the RAR agonist is an RAR? agonist. In one embodiment, administration of the RAR agonist is begun during a period of increased endogenous retinoid signaling in the subject resulting from incurrence of the damaged muscle tissue.Type: ApplicationFiled: August 4, 2022Publication date: June 29, 2023Inventors: Masahiro IWAMOTO, Maurizio PACIFICI
-
Publication number: 20230116835Abstract: A service providing mobile unit 1 comprised of a frame 2 forming a ring shape about a horizontal axis, movement-use wheels 4, 5 attached to the bottom part of the frame 2, a hydrogen storage tank insert pan 10 formed inside the frame 2, and a fuel cell 40 arranged inside the frame 2. Hydrogen is supplied to the fuel cell 40 from a replaceable hydrogen storage tank 20 inserted into the hydrogen storage tank insert part 10. A service providing space 3 having a ring-shaped inner circumference surface of the frame 2 as its outer edges is formed by the frame 2, and power can be supplied from the fuel cell 40 to a service providing unit installed inside the service providing space 3.Type: ApplicationFiled: October 6, 2022Publication date: April 13, 2023Applicant: TOYOTA JIDOSHA KABUSHIKI KAISHAInventors: Masashi NAKAMURA, Zixun MEI, Nobuyuki TOMATSU, Masashi NAKAMURA, Junichi OURA, Yusuke NISHIDA, Yuki BISAIJI, Masahiro IWAMOTO, Takao KATAOKA, Tatsuyuki HAYASHI, Saki MORIMOTO
-
Patent number: 11433039Abstract: The invention provides methods for muscle repair or regeneration comprising administering therapeutically effective amounts of RAR agonists or stem cells that are pretreated with contact with a RAR agonist to a subject at a site of muscle damage. Additionally, the invention provides compositions comprising RAR agonist treated stem cells and methods of use of said cells for muscle repair or regeneration. In one embodiment, the stem cells are mesenchymal stem cells. In one embodiment, the RAR agonist is an RAR? agonist. In one embodiment, administration of the RAR agonist is begun during a period of increased endogenous retinoid signaling in the subject resulting from incurrence of the damaged muscle tissue.Type: GrantFiled: April 9, 2019Date of Patent: September 6, 2022Assignee: Thomas Jefferson UniversityInventors: Masahiro Iwamoto, Maurizio Pacifici
-
Patent number: 11242471Abstract: The present invention relates to a conductive composition containing a conductive metal powder and a resin component, in which the conductive metal powder contains at least a metal flake having a crystalline structure in which a metal crystal grows in a flake shape, and the resin component contains an aromatic amine skeleton.Type: GrantFiled: February 12, 2015Date of Patent: February 8, 2022Assignee: Mitsuboshi Belting Ltd.Inventors: Taisuke Iseda, Masahiro Iwamoto
-
Patent number: 11118899Abstract: A work support system includes a measurement apparatus measuring a state of each of multiple measurement points on an object surface of a workpiece, a projector apparatus, and an arithmetic apparatus creating a projection image of the projector apparatus based on a measurement result of the measurement apparatus. The arithmetic apparatus calculates a difference between a state measured by the measurement apparatus and a target state for each of the multiple measurement points, and creates the projection image such that a picture of a characteristic point representative of the difference at each of the multiple measurement points is projected by the projector apparatus at a position of a corresponding measurement point on the object surface of the workpiece.Type: GrantFiled: October 11, 2018Date of Patent: September 14, 2021Assignee: KAWASAKI JUKOGYO KABUSHIKI KAISHAInventors: Atsuki Nakagawa, Naohiro Nakamura, Masahiro Iwamoto, Shigekazu Shikoda
-
Publication number: 20210189204Abstract: An adhesive containing at least one selected from the group consisting of a urethane prepolymer and a polyol, a polyisocyanate, a polymerizable (meth)acrylate compound, and a photopolymerization initiator is disclosed. A heat-sensitive screen master and a method for producing a heat-sensitive screen master are also disclosed.Type: ApplicationFiled: December 21, 2020Publication date: June 24, 2021Inventors: Hirotaka TOMINAGA, Tomoko TERANAKA, Masahiro IWAMOTO
-
Publication number: 20200318950Abstract: A work support system includes a measurement apparatus measuring a state of each of multiple measurement points on an object surface of a workpiece, a projector apparatus, and an arithmetic apparatus creating a projection image of the projector apparatus based on a measurement result of the measurement apparatus. The arithmetic apparatus calculates a difference between a state measured by the measurement apparatus and a target state for each of the multiple measurement points, and creates the projection image such that a picture of a characteristic point representative of the difference at each of the multiple measurement points is projected by the projector apparatus at a position of a corresponding measurement point on the object surface of the workpiece.Type: ApplicationFiled: October 11, 2018Publication date: October 8, 2020Applicant: KAWASAKI JUKOGYO KABUSHIKI KAISHAInventors: Atsuki NAKAGAWA, Naohiro NAKAMURA, Masahiro IWAMOTO, Shigekazu SHIKODA
-
Patent number: 10707323Abstract: Metal contact openings are etched in the barrier layer of a group III-N HEMT with a first gas combination that etches down into the barrier layer, and a second gas combination that etches further down into the barrier layer to a depth that lies above the top surface of a channel layer that touches and lies below the barrier layer.Type: GrantFiled: May 23, 2019Date of Patent: July 7, 2020Assignee: TEXAS INSTRUMENTS INCORPORATEDInventors: Yoshikazu Kondo, Shoji Wada, Hiroshi Yamasaki, Masahiro Iwamoto
-
Publication number: 20200197321Abstract: The invention relates to compositions and methods as part of a pharmacotherapeutic strategy that targets the endochondral ossification process in a pharmacologically selective and site-specific manner. A variety of orthopedic pathologies are caused by or associated with generalized or local dysregulation of endochondral ossification, for example trauma to the bone growth plate or diaphysis can cause a serious imbalance in bone growth, leading to progressive deformity that today can only be treated surgically. Dysregulated endochondral ossification is also behind heterotopic ossification, which arises in soft tissues and causes pain, decrease in mobility and other clinical problems. The invention therefore provides RARy agonist and antagonist nanoparticle compositions for treating abnormal endochondral ossification and bone growth that can deliver robust local therapeutic control over a particular long bone's growth with a long-lasting effect.Type: ApplicationFiled: June 20, 2018Publication date: June 25, 2020Inventors: Masahiro Iwamoto, Michael Chorny
-
Publication number: 20200069620Abstract: The invention provides methods for muscle repair or regeneration comprising administering therapeutically effective amounts of RAR agonists or stem cells that are pretreated with contact with a RAR agonist to a subject at a site of muscle damage. Additionally, the invention provides compositions comprising RAR agonist treated stem cells and methods of use of said cells for muscle repair or regeneration. In one embodiment, the stem cells are mesenchymal stem cells. In one embodiment, the RAR agonist is an RAR? agonist. In one embodiment, administration of the RAR agonist is begun during a period of increased endogenous retinoid signaling in the subject resulting from incurrence of the damaged muscle tissue.Type: ApplicationFiled: April 9, 2019Publication date: March 5, 2020Inventors: Masahiro IWAMOTO, Maurizio PACIFICI
-
Publication number: 20190288090Abstract: Metal contact openings are etched in the barrier layer of a group III-N HEMT with a first gas combination that etches down into the barrier layer, and a second gas combination that etches further down into the barrier layer to a depth that lies above the top surface of a channel layer that touches and lies below the barrier layer.Type: ApplicationFiled: May 23, 2019Publication date: September 19, 2019Inventors: Yoshikazu Kondo, Shoji Wada, Hiroshi Yamasaki, Masahiro Iwamoto
-
Patent number: 10374057Abstract: Metal contact openings are etched in the barrier layer of a group III-N HEMT with a first gas combination that etches down into the barrier layer, and a second gas combination that etches further down into the barrier layer to a depth that lies above the top surface of a channel layer that touches and lies below the barrier layer.Type: GrantFiled: October 12, 2017Date of Patent: August 6, 2019Assignee: TEXAS INSTRUMENTS INCORPORATEDInventors: Yoshikazu Kondo, Shoji Wada, Hiroshi Yamasaki, Masahiro Iwamoto
-
Patent number: 10292954Abstract: The invention provides methods for muscle repair or regeneration comprising administering therapeutically effective amounts of RAR agonists or stem cells that are pretreated with contact with a RAR agonist to a subject at a site of muscle damage. Additionally, the invention provides compositions comprising RAR agonist treated stem cells and methods of use of said cells for muscle repair or regeneration. In one embodiment, the stem cells are mesenchymal stem cells. In one embodiment, the RAR agonist is an RAR? agonist. In one embodiment, administration of the RAR agonist is begun during a period of increased endogenous retinoid signaling in the subject resulting from incurrence of the damaged muscle tissue.Type: GrantFiled: August 10, 2017Date of Patent: May 21, 2019Assignee: Thomas Jefferson UniversityInventors: Masahiro Iwamoto, Maurizio Pacifici
-
Patent number: 10285280Abstract: The present invention relates to a conductive adhesive for screen printing containing metal colloid particles (A) containing metal nanoparticles (A1) and a protective colloid (A2) containing an organic compound having a carboxyl group and a polymer dispersant having a carboxyl group, a viscosity modifier (B) having an amide bond and/or a urea bond, and a dispersion solvent (C).Type: GrantFiled: December 21, 2012Date of Patent: May 7, 2019Assignee: Mitsuboshi Belting Ltd.Inventors: Taisuke Iseda, Kazutomo Kawahara, Masahiro Iwamoto
-
Patent number: 10132231Abstract: A control apparatus for an internal combustion engine is configured, when regenerative processing by an electric supercharger is executed, to control the opening degree of a throttle valve, the opening degree of an intake bypass valve and the power generation load on a motor generator to set the opening degree of the intake bypass valve and the power regeneration load so that a second intake pressure which is an intake pressure downstream of an electric compressor and upstream of a turbo compressor does not fall below a second specific pressure value, based on a request intake air flow rate of the internal combustion engine and the second intake pressure.Type: GrantFiled: June 30, 2016Date of Patent: November 20, 2018Assignee: TOYOTA JIDOSHA KABUSHIKI KAISHAInventor: Masahiro Iwamoto
-
Publication number: 20180222988Abstract: A therapeutic agent for chronic arthritides diseases of childhood-related diseases, for example chronic arthritides diseases of childhood, Still's disease and the like, comprising an interleukin-6 (IL-6) antagonist as an active ingredient.Type: ApplicationFiled: April 6, 2018Publication date: August 9, 2018Applicant: Chugai Seiyaku Kabushiki KaishaInventors: Kazuyuki Yoshizaki, Norihiro Nishimoto, Masahiro Iwamoto, Seiji Minota, Shumpei Yokota, Takako Miyamae
-
Patent number: 9991882Abstract: A semiconductor apparatus includes an internal circuit connected to a first power line to which a first power voltage is applied; a transistor including a first terminal, which is connected to a node to which an input voltage is applied, a second terminal connected to the internal circuit, and a control terminal to which a control voltage is applied; and a voltage control circuit, which is connected to the node, generating the control voltage. Further, the voltage control circuit includes a step-down circuit generating an internal voltage by lowering the input voltage applied to the node, and a switching circuit, which is connected to the first power line, generating the control voltage based on the first power voltage and the internal voltage.Type: GrantFiled: November 15, 2017Date of Patent: June 5, 2018Assignee: SOCIONEXT INC.Inventors: Hajime Ohmi, Osamu Uno, Masahiro Iwamoto, Yuichi Itonaga
-
Publication number: 20180076809Abstract: A semiconductor apparatus includes an internal circuit connected to a first power line to which a first power voltage is applied; a transistor including a first terminal, which is connected to a node to which an input voltage is applied, a second terminal connected to the internal circuit, and a control terminal to which a control voltage is applied; and a voltage control circuit, which is connected to the node, generating the control voltage. Further, the voltage control circuit includes a step-down circuit generating an internal voltage by lowering the input voltage applied to the node, and a switching circuit, which is connected to the first power line, generating the control voltage based on the first power voltage and the internal voltage.Type: ApplicationFiled: November 15, 2017Publication date: March 15, 2018Inventors: Hajime OHMI, Osamu Uno, Masahiro Iwamoto, Yuichi Itonaga